$ Value
$3K
Shares
1,517
Price
$2
Filed
Mar 12
Insider
Name
Boniface John J.
Title
Chief Scientific Officer
CIK
0001870674
Roles
Transaction Details
Transaction Date
2026-03-11
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
145,842
Footnotes
Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by "sell to cover" transactions and does not represent a discretionary transaction by the Reporting Person. | The price reported is a weighted average price. These shares were sold as part of a block trade in multiple transactions at prices ranging from $1.90 to $2.30, inclusive. The Reporting Person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price with regard to the block trade.
Filing Info
Boniface John J.'s History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-11 | SERA | ▼ | $3K |
| 2026-03-09 | SERA | ▼ | $6K |
| 2025-12-10 | SERA | ▼ | $4K |
| 2025-11-10 | SERA | ▼ | $20K |
| 2025-09-11 | SERA | ▼ | $4K |
| 2025-08-08 | SERA | ▼ | $18K |
| 2025-06-10 | SERA | ▼ | $2K |
| 2025-05-30 | SERA | A | $5K |
| 2025-05-08 | SERA | ▼ | $13K |
Other Insiders at SERA (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| Lawrence Sandra AJ | — | $3K | 2026-03-06 |
|
Harrison Robert Gardner
Chief Information Officer
|
— | $19K | 2026-03-11 |
| Kamdar Kim P. | — | — | 2026-02-04 |
|
Jackson Benjamin
General Counsel
|
— | $8K | 2026-03-12 |
|
Boniface John J.
Chief Scientific Officer
|
— | $6K | 2026-03-09 |
|
Kearney Paul
Chief Data Officer
|
— | $7K | 2026-03-11 |
|
Lindgardt Zhenya
Chief Executive Officer
|
— | $49K | 2026-03-12 |
|
Aerts Austin
Chief Financial Officer
|
— | $15K | 2026-03-12 |
|
Anderson Dyaarl Lee Jr.
Chief Commercial Officer
|
— | — | 2026-03-12 |
|
Inglis Tiffany Eul Davis
Chief Medical Officer
|
— | — | 2026-03-12 |